10. Series B Convertible Preferred Stock Warrants (Details - Warrants Outstanding) - Warrants [Member] |
6 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
$ / shares
shares
| |
Number of units | |
Outstanding, beginning of period | 118,029 |
Granted | 0 |
Exercised | 0 |
Outstanding, end of period | 118,029 |
Exercisable, end of period | 118,029 |
Weighted Average Exercise Price | |
Outstanding, beginning of period | $ / shares | $ 20.80 |
Granted | $ / shares | |
Outstanding, end of period | $ / shares | 20.80 |
Exercisable, end of period | $ / shares | $ 20.80 |
Weighted Average Remaining Contractual Term (in years) | |
Outstanding, beginning of period | 1 year 8 months 23 days |
Outstanding, end of period | 1 year 2 months 23 days |
Exercisable, end of period | 1 year 5 months 23 days |
Intrinsic value outstanding, beginning of period | $ | $ 4,307,493 |
Intrinsic value outstanding, end of period | $ | $ 6,927,742 |
Exercisable, end of period | 6,927,741 |
X | ||||||||||
- Definition Number of warrants [Abstract] No definition available.
|
X | ||||||||||
- Definition ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1 No definition available.
|
X | ||||||||||
- Definition Exercisable, end of period No definition available.
|
X | ||||||||||
- Definition Exercisable, end of period No definition available.
|
X | ||||||||||
- Definition Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options. No definition available.
|
X | ||||||||||
- Definition Intrinsic value exercisable No definition available.
|
X | ||||||||||
- Definition Weighted Average Remaining Contractual Term (in years) exercisable No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price [Abstract] No definition available.
|
X | ||||||||||
- Definition Weighted Average Remaining Contractual Term (in years) [Abstract] No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options. No definition available.
|
X | ||||||||||
- Details
|